Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,123 | 54 | 91.8% |
| Education | $99.99 | 1 | 8.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $220.39 | 12 | $0 (2024) |
| Paratek Pharmaceuticals, Inc. | $208.72 | 10 | $0 (2023) |
| Amarin Pharma Inc. | $166.31 | 8 | $0 (2022) |
| Relievant Medsystems, Inc. | $120.32 | 1 | $0 (2021) |
| Astellas Pharma US Inc | $116.44 | 2 | $0 (2021) |
| Nabriva Therapeutics, plc | $96.96 | 5 | $0 (2022) |
| ABBVIE INC. | $57.39 | 3 | $0 (2022) |
| Abbott Laboratories | $49.50 | 3 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $32.80 | 2 | $0 (2022) |
| SHIELD THERAPEUTICS INC | $22.64 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $159.39 | 8 | Novo Nordisk Inc ($136.75) |
| 2023 | $95.28 | 5 | Paratek Pharmaceuticals, Inc. ($42.99) |
| 2022 | $421.09 | 21 | Paratek Pharmaceuticals, Inc. ($165.73) |
| 2021 | $547.49 | 21 | Relievant Medsystems, Inc. ($120.32) |
All Payment Transactions
55 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: Obesity | ||||||
| 11/07/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $29.58 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Diabetes | ||||||
| 09/06/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: Obesity | ||||||
| 08/23/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Diabetes | ||||||
| 08/12/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: Hematology | ||||||
| 07/29/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Diabetes | ||||||
| 06/14/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: Diabetes Care | ||||||
| 05/30/2023 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: ANTIBIOTIC | ||||||
| 05/16/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/21/2023 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: ANTIBIOTIC | ||||||
| 02/14/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Diabetes | ||||||
| 12/19/2022 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $6.31 | General |
| Category: ANTIBIOTIC | ||||||
| 11/19/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.85 | General |
| 11/17/2022 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: ANTIBIOTIC | ||||||
| 11/04/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/17/2022 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: ANTIBIOTIC | ||||||
| 09/28/2022 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: ANTIBIOTIC | ||||||
| 08/16/2022 | Nabriva Therapeutics, plc | Sivextro (Drug) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: Oxazolidinone antibiotics | ||||||
| 08/09/2022 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: ANTIBIOTIC | ||||||
| 07/12/2022 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: ANTIBIOTIC | ||||||
| 06/21/2022 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: ANTIBIOTIC | ||||||
| 06/13/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/24/2022 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: ANTIBIOTIC | ||||||
About Christopher Egan, PA
Christopher Egan, PA is a Surgical healthcare provider based in West Hempstead, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/20/2007. The National Provider Identifier (NPI) number assigned to this provider is 1992998330.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Christopher Egan, PA has received a total of $1,223 in payments from pharmaceutical and medical device companies, with $159.39 received in 2024. These payments were reported across 55 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,123).
Practice Information
- Specialty Surgical
- Other Specialties Family Medicine
- Location West Hempstead, NY
- Active Since 08/20/2007
- Last Updated 08/26/2025
- Taxonomy Code 363AS0400X
- Entity Type Individual
- NPI Number 1992998330
Products in Payments
- NUZYRA (Drug) $208.72
- Vascepa (Drug) $166.31
- Intracept (Device) $120.32
- Ozempic (Drug) $78.08
- Xenleta (Drug) $55.10
- Sivextro (Drug) $41.86
- UBRELVY (Drug) $38.31
- Rybelsus (Drug) $37.90
- Wegovy (Drug) $34.10
- ENTRESTO (Drug) $32.80
- FreeStyle Libre 2 (Device) $27.22
- ACCRUFER (Drug) $22.64
- PREVNAR 20 (Biological) $22.44
- FREESTYLE LIBRE 2 (Device) $22.28
- QULIPTA (Drug) $19.08
- (8874) inCourage (Device) $17.74
- GIMOTI (Drug) $17.03
- MYRBETRIQ (Drug) $16.45
- MOUNJARO (Drug) $16.28
- RYBELSUS (Drug) $15.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.